u/JiiJiiRoman

Reddit r/wallstreetbets
· tracked since Jan 2026
Calls
1
Win Rate
-
return
-
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate - Long 1 Short 0
Win Rate
7d
30d
90d
Average Return - Long Return - Short Return -
Average Return
7d
30d
90d
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 03
$4.35
-
SELLAS GPS may be first/best-in-class AML treatment.
The author argues that SELLAS Life Sciences' cancer vaccine GPS has demonstrated much longer overall survival than current standard of care in AML, with >60 months first-line and 21 months second-line versus 18-24 months and under a year. Because GPS is an off-the-shelf subcutaneous vaccine with no harmful side effects beyond local reactions, he expects the ongoing REGAL Phase 3 trial to match or exceed prior results as it runs longer. He urges others to research SLS and believes GPS could be a first-in-class/best-in-class AML treatment, while acknowledging the drug could still fail.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

u/JiiJiiRoman has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology